239 related articles for article (PubMed ID: 22490627)
21. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
[TBL] [Abstract][Full Text] [Related]
22. [Renal artery denervation for treating refractory hypertension].
Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
[TBL] [Abstract][Full Text] [Related]
23. Renal denervation and hypertension.
Schlaich MP; Krum H; Sobotka PA; Esler MD
Am J Hypertens; 2011 Jun; 24(6):635-42. PubMed ID: 21394087
[TBL] [Abstract][Full Text] [Related]
24. Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep.
Booth LC; Nishi EE; Yao ST; Ramchandra R; Lambert GW; Schlaich MP; May CN
Hypertension; 2015 Feb; 65(2):393-400. PubMed ID: 25403610
[TBL] [Abstract][Full Text] [Related]
25. Beneficial Effects of Renal Denervation on Pulmonary Vascular Remodeling in Experimental Pulmonary Artery Hypertension.
Qingyan Z; Xuejun J; Yanhong T; Zixuan D; Xiaozhan W; Xule W; Zongwen G; Wei H; Shengbo Y; Congxin H
Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):562-70. PubMed ID: 25804321
[TBL] [Abstract][Full Text] [Related]
26. 3D-sympathetic renal denervation increases procedural efficacy in non-responders after percutaneous renal denervation: dream or reality with second generation of devices.
Versaci F; Nardi S; Trivisonno A; Olivieri C; Caranci F; Prati F
Int J Cardiol; 2014 Aug; 175(2):370-1. PubMed ID: 24820742
[No Abstract] [Full Text] [Related]
27. [Renal sympathetic denervation: perspective of a promising treatment for hypertension].
Cassat M; Wuerzner G; Pruijm M; Forni V; Burnier M
Rev Med Suisse; 2011 Sep; 7(308):1743-7. PubMed ID: 21954814
[TBL] [Abstract][Full Text] [Related]
28. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.
Hiremath S; Froeschl M; Ruzicka M
Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619
[TBL] [Abstract][Full Text] [Related]
29. Renal denervation: current implications and future perspectives.
Xu J; Hering D; Sata Y; Walton A; Krum H; Esler MD; Schlaich MP
Clin Sci (Lond); 2014 Jan; 126(1):41-53. PubMed ID: 24020446
[TBL] [Abstract][Full Text] [Related]
30. [Catheter-based renal sympathetic denervation for the treatment of resistant arterial hypertension in Poland - experts consensus statement].
Witkowski A; Januszewicz A; Imiela J; Narkiewicz K; Opolski G; Rowiński O; Sadowski J; Dudek D; Bryniarski L; Gil RJ; Adamczak M; Grajek S; Kądziela J; Prejbisz A; Nowicki M
Kardiol Pol; 2011; 69(11):1208-11. PubMed ID: 22090243
[No Abstract] [Full Text] [Related]
31. Renal denervation for hypertension.
Eleid MF; Schwartz GL; Gulati R
Curr Probl Cardiol; 2014 Feb; 39(2):35-51. PubMed ID: 24412003
[TBL] [Abstract][Full Text] [Related]
32. Effects and Mechanisms of Radiofrequency Ablation of Renal Sympathetic Nerve on Anti-Hypertension in Canine.
Chen W; Tang X; Yang X; Weng C; Yang K; Wen J; Liu H; Wu Y
Arq Bras Cardiol; 2017 Mar; 108(3):237-245. PubMed ID: 28273198
[TBL] [Abstract][Full Text] [Related]
33. [Changes of blood pressure and S-100B, neuron specific enolase protein in hypertensive dogs after renal sympathetic denervation].
Jiang F; Wang X; Zhu F; Zeng L; Wang X; Li H; Shen Z; Yang K; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 39(3):245-51. PubMed ID: 24748198
[TBL] [Abstract][Full Text] [Related]
34. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M
Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238
[TBL] [Abstract][Full Text] [Related]
35. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients.
Vink EE; Verloop WL; Siddiqi L; van Schelven LJ; Liam Oey P; Blankestijn PJ
Int J Cardiol; 2014 Sep; 176(1):8-12. PubMed ID: 25027168
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous renal sympathetic denervation: 2013 and beyond.
Froeschl M; Hadziomerovic A; Ruzicka M
Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191
[TBL] [Abstract][Full Text] [Related]
37. Global- and renal-specific sympathoinhibition in aldosterone hypertension.
Lohmeier TE; Liu B; Hildebrandt DA; Cates AW; Georgakopoulos D; Irwin ED
Hypertension; 2015 Jun; 65(6):1223-30. PubMed ID: 25895584
[TBL] [Abstract][Full Text] [Related]
38. Low-dose sustained-release deoxycorticosterone acetate-induced hypertension in Bama miniature pigs for renal sympathetic nerve denervation.
Han W; Fang W; Gan Q; Guan S; Li Y; Wang M; Gong K; Qu X
J Am Soc Hypertens; 2017 May; 11(5):314-320. PubMed ID: 28411074
[TBL] [Abstract][Full Text] [Related]
39. Denervation of nerve terminals in renal arteries: one-year follow-up of interventional treatment of arterial hypertension.
Bartuś K; Sadowski J; Kapelak B; Litwinowicz R; Zajdel W; Godlewski J; Bartuś M; Zmudka K; Chrapusta A; Konstanty-Kalandyk J; Węgrzyn P; Sobotka PA
Kardiol Pol; 2014; 72(5):425-31. PubMed ID: 24408071
[TBL] [Abstract][Full Text] [Related]
40. Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension.
Brandt MC; Reda S; Mahfoud F; Lenski M; Böhm M; Hoppe UC
J Am Coll Cardiol; 2012 Nov; 60(19):1956-65. PubMed ID: 23062529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
